新型冠状病毒实验室检测专家共识

  • 摘要: 新型冠状病毒肺炎疫情仍在全球肆虐,实验室检测是疫情防控的关键环节。基于目前实验室检测所积累的经验和难点,结合当前最新研究进展,中国医院协会临床微生物实验室专业委员会组织临床微生物学、分子生物学和免疫学检验相关专家共同制定了《新型冠状病毒实验室检测专家共识》。本共识对新型冠状病毒临床常用检测方法,尤其是核酸、抗体及抗原检测的技术特点、应用注意事项及生物安全要求进行了详细介绍,就目前新型冠状病毒实验室检测和结果解读方面的常见问题提出了解决方案,对核酸和抗体联合检测在不同病程阶段的临床应用及其意义进行了解读,以期为常态化疫情防控期间临床实验室开展新型冠状病毒精准检测提供参考。

     

    Abstract: With the global outbreak of the coronavirus disease 2019, the laboratory testing for the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has become the key to the epidemic prevention and control. Based on the questions, issues from the clinical practice and the latest research, the Sub-committee of Clinical Microbiology Laboratory, Chinese Hospital Association proposed "Expert Consensus on Laboratory Testing for SARS-CoV-2". The consensus panel is composed by experts in clinical microbiology, molecular biology and immunology laboratory medicine. The consensus describes the technological characteristics, precautions of clinical application, and biosafety requirements. It also includes the coping strategies for the most frequent problems and the challenges in testing and results explanation of commonly used clinical methods including nucleic acid, antibody and antigen tests, and combined testing of nucleic acid and antibody. We expect this consensus could provide guidances and reference opinions on how to conduct the precise laboratory testing for SARS-CoV-2 on the epidemic prevention and control.

     

/

返回文章
返回